Amalgamated Bank Edwards Lifesciences Corp Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Amalgamated Bank holds 119,754 shares of EW stock, worth $8.11 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
119,754
Previous 123,121 2.73%
Holding current value
$8.11 Million
Previous $11.4 Million 30.51%
% of portfolio
0.07%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$59.7 - $93.78 $201,009 - $315,757
-3,367 Reduced 2.73%
119,754 $7.9 Million
Q2 2024

Aug 12, 2024
SELL
$84.3 - $94.31 $640,680 - $716,756
-7,600 Reduced 5.81%
123,121 $11.4 Million
Q1 2024

Apr 23, 2024
SELL
$72.54 - $95.56 $1.5 Million - $1.97 Million
-20,649 Reduced 13.64%
130,721 $12.5 Million
Q4 2023

Feb 06, 2024
SELL
$61.71 - $77.76 $637,279 - $803,027
-10,327 Reduced 6.39%
151,370 $11.5 Million
Q3 2023

Nov 08, 2023
SELL
$69.28 - $93.38 $933,894 - $1.26 Million
-13,480 Reduced 7.7%
161,697 $11.2 Million
Q2 2023

Aug 11, 2023
BUY
$81.41 - $94.33 $619,041 - $717,285
7,604 Added 4.54%
175,177 $16.5 Million
Q1 2023

May 02, 2023
SELL
$74.26 - $84.51 $60,076 - $68,368
-809 Reduced 0.48%
167,573 $13.9 Million
Q4 2022

Feb 10, 2023
SELL
$68.3 - $87.44 $181,063 - $231,803
-2,651 Reduced 1.55%
168,382 $12.6 Million
Q3 2022

Nov 09, 2022
BUY
$82.37 - $107.29 $478,157 - $622,818
5,805 Added 3.51%
171,033 $14.1 Million
Q2 2022

Aug 15, 2022
SELL
$86.5 - $128.27 $855,917 - $1.27 Million
-9,895 Reduced 5.65%
165,228 $15.7 Million
Q1 2022

Jun 30, 2022
BUY
$101.96 - $128.34 $727,688 - $915,962
7,137 Added 4.25%
175,123 $20.6 Million
Q4 2021

Feb 15, 2022
BUY
$106.37 - $130.68 $3.04 Million - $3.73 Million
28,573 Added 20.5%
167,986 $21.8 Million
Q3 2021

Oct 29, 2021
SELL
$102.91 - $122.75 $653,272 - $779,217
-6,348 Reduced 4.36%
139,413 $15.8 Million
Q2 2021

Aug 16, 2021
BUY
$83.84 - $104.76 $9.03 Million - $11.3 Million
107,749 Added 283.46%
145,761 $15.1 Million
Q1 2021

May 13, 2021
SELL
$78.68 - $90.67 $141,466 - $163,024
-1,798 Reduced 4.52%
38,012 $3.18 Million
Q4 2020

Feb 12, 2021
SELL
$71.69 - $91.23 $13,621 - $17,333
-190 Reduced 0.48%
39,810 $3.63 Million
Q3 2020

Oct 30, 2020
SELL
$67.19 - $87.44 $80,628 - $104,928
-1,200 Reduced 2.91%
40,000 $3.19 Million
Q2 2020

Aug 10, 2020
BUY
$57.54 - $76.95 $364,746 - $487,786
6,339 Added 18.18%
41,200 $2.85 Million
Q1 2020

May 13, 2020
SELL
$52.41 - $81.0 $59,957 - $92,664
-1,144 Reduced 3.18%
34,861 $6.58 Million
Q4 2019

Feb 13, 2020
BUY
$71.7 - $82.09 $104,682 - $119,851
1,460 Added 4.23%
36,005 $8.4 Million
Q3 2019

Nov 13, 2019
BUY
$61.55 - $75.43 $430,850 - $528,010
7,000 Added 25.41%
34,545 $7.6 Million
Q2 2019

Aug 14, 2019
SELL
$55.74 - $64.41 $222,291 - $256,867
-3,988 Reduced 12.65%
27,545 $5.09 Million
Q1 2019

May 15, 2019
BUY
$47.89 - $64.05 $31,559 - $42,208
659 Added 2.13%
31,533 $6.03 Million
Q4 2018

Feb 15, 2019
SELL
$46.41 - $56.94 $41,258 - $50,619
-889 Reduced 2.8%
30,874 $4.73 Million
Q3 2018

Nov 14, 2018
SELL
$45.7 - $58.03 $46,248 - $58,726
-1,012 Reduced 3.09%
31,763 $5.53 Million
Q2 2018

Jul 18, 2018
BUY
$42.45 - $51.3 $90,800 - $109,730
2,139 Added 6.98%
32,775 $4.77 Million
Q1 2018

May 22, 2018
BUY
$37.19 - $47.45 $111,272 - $141,970
2,992 Added 10.82%
30,636 $4.27 Million
Q4 2017

Feb 13, 2018
BUY
$33.79 - $39.39 $81,771 - $95,323
2,420 Added 9.59%
27,644 $3.12 Million
Q3 2017

Nov 09, 2017
BUY
$36.29 - $38.83 $915,378 - $979,447
25,224
25,224 $2.76 Million

Others Institutions Holding EW

# of Institutions
1,351
Shares Held
455M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email